FOXM1 and pulmonary fibrosis: This article introduces and reviews the functions and mechanisms of FOXM1 in diabetes and its complications, pulmonary fibrosis, inflammation, and myasthenia gravis, as well as the growth and development of patients, in order to provide an essential basis for clinical treatment and applications and future research.